MedPath

UNIVERSITY OF WASHINGTON

UNIVERSITY OF WASHINGTON logo
🇺🇸United States
Ownership
Private
Established
1861-01-01
Employees
10K
Market Cap
-
Website
https://www.cs.washington.edu

Nivolumab and Ipilimumab and Stereotactic Body Radiation Therapy in Treating Patients With Salivary Gland Cancers

Phase 1
Completed
Conditions
Metastatic Malignant Neoplasm in the Lung
Salivary Gland Carcinoma
Stage IV Major Salivary Gland Cancer AJCC v8
Stage IVB Major Salivary Gland Cancer AJCC v8
Stage IVA Major Salivary Gland Cancer AJCC v8
Stage IVC Major Salivary Gland Cancer AJCC v8
Metastatic Malignant Neoplasm in the Bone
Interventions
Biological: Nivolumab
Biological: Ipilimumab
Radiation: Stereotactic Body Radiation Therapy
First Posted Date
2018-11-21
Last Posted Date
2023-12-29
Lead Sponsor
University of Washington
Target Recruit Count
20
Registration Number
NCT03749460
Locations
🇺🇸

Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Latina Friends Motivating the Soul (ALMA)

Not Applicable
Withdrawn
Conditions
Stress
Depression
Anxiety
Interventions
Behavioral: Latina Friends Motivating the Soul (ALMA)
First Posted Date
2018-11-21
Last Posted Date
2023-05-10
Lead Sponsor
University of Washington
Registration Number
NCT03749278
Locations
🇺🇸

El Centro de la Raza, Seattle, Washington, United States

🇺🇸

Casa Latina, Seattle, Washington, United States

Project to Improve Communication About Serious Illness - Pilot Study

Not Applicable
Completed
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
Congestive Heart Failure
Dementia
Peripheral Vascular Disease
Diabetes Complications
Malignant Neoplasm
Renal Insufficiency, Chronic
Lung Disease Chronic
Liver Failures, Chronic
Frail Elderly
Interventions
Behavioral: Jumpstart Intervention
First Posted Date
2018-11-19
Last Posted Date
2020-11-04
Lead Sponsor
University of Washington
Target Recruit Count
150
Registration Number
NCT03746392
Locations
🇺🇸

Harborview Medical Center, Seattle, Washington, United States

🇺🇸

University of Washington Medical Center, Seattle, Washington, United States

Strategies to Improve Pain and Enjoy Life

Not Applicable
Completed
Conditions
Chronic Pain
Interventions
Behavioral: Pain self-management training
Other: usual care
Behavioral: video education, motivational interviewing
Behavioral: voluntary self-paced opioid taper
Behavioral: prescribing guidance for primary care provider
First Posted Date
2018-11-16
Last Posted Date
2023-04-07
Lead Sponsor
University of Washington
Target Recruit Count
153
Registration Number
NCT03743402
Locations
🇺🇸

Kaiser Permanente Washington, Seattle, Washington, United States

Multiparametric MRI for Assessing Breast Cancer Response to Anti-HER2 Therapy

Active, not recruiting
Conditions
HER2-positive Breast Cancer
First Posted Date
2018-11-13
Last Posted Date
2025-01-27
Lead Sponsor
University of Washington
Target Recruit Count
13
Registration Number
NCT03738553
Locations
🇺🇸

Seattle Cancer Care Alliance, Seattle, Washington, United States

Fractionated Gemtuzumab Ozogamicin in Treating Measurable Residual Disease in Patients With Acute Myeloid Leukemia

Phase 2
Recruiting
Conditions
Acute Myeloid Leukemia
Interventions
Other: Quality-of-Life Assessment
First Posted Date
2018-11-13
Last Posted Date
2025-01-14
Lead Sponsor
University of Washington
Target Recruit Count
36
Registration Number
NCT03737955
Locations
🇺🇸

Fred Hutchinson Cancer Center/University of Washington Cancer Consortium, Seattle, Washington, United States

Increasing Enteral Protein Intake in Critically Ill Trauma and Surgical Patients

Not Applicable
Completed
Conditions
Critical Illness
Malnutrition
Enteral Nutrition
Protein Supplementation
Interventions
Dietary Supplement: Modular enteral protein - Prosource
First Posted Date
2018-11-07
Last Posted Date
2018-11-07
Lead Sponsor
University of Washington
Target Recruit Count
118
Registration Number
NCT03733782

Nicotinamide Riboside in LVAD Recipients

Early Phase 1
Completed
Conditions
Heart Failure New York Heart Association Class IV
Mitochondrial Alteration
Heart Failure,Congestive
Interventions
Dietary Supplement: Nicotinamide riboside
First Posted Date
2018-11-01
Last Posted Date
2020-09-01
Lead Sponsor
University of Washington
Target Recruit Count
5
Registration Number
NCT03727646
Locations
🇺🇸

University of Washington, Seattle, Washington, United States

Occupational Therapist-Led Work Intervention in Facilitating Work Maintenance or Re-entry to the Workforce in Patients With Stage I to III Breast Cancer Undergoing Chemotherapy

Not Applicable
Terminated
Conditions
Breast Cancer Stage IIB
Breast Cancer Stage III
Breast Cancer Stage IIA
Breast Cancer Stage IIIc
Breast Cancer Stage I
Breast Cancer Stage II
Breast Cancer Stage IIIB
Breast Cancer Stage IIIA
Breast Cancer
Interventions
Behavioral: Occupational Therapy
First Posted Date
2018-10-30
Last Posted Date
2021-07-06
Lead Sponsor
University of Washington
Target Recruit Count
15
Registration Number
NCT03723863
Locations
🇺🇸

Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Facilitating Communication Study

Not Applicable
Completed
Conditions
Chronic Disease
Neoplasm Metastasis
Liver Cirrhosis
Palliative Care, Patient Care
Health Care Quality, Access, and Evaluation
Heart Failure, Congestive
Kidney Failure, Chronic
Intensive Care Units
Lung Neoplasm
Multiple Organ Failure
Interventions
Behavioral: Facilitator-Based Intervention
First Posted Date
2018-10-26
Last Posted Date
2025-02-07
Lead Sponsor
University of Washington
Target Recruit Count
977
Registration Number
NCT03721952
Locations
🇺🇸

UW Medicine - Harborview Medical Center, Seattle, Washington, United States

🇺🇸

University of Washington Medical Center - Northwest, Seattle, Washington, United States

🇺🇸

University of Washington Medical Center - Montlake, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath